Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 11105 - 11112 of 12039 results
Updated Self-Disclosure Protocol Clarifies Disclosure Process and Obligations
April 22, 2013| Advisory| Viewpoint
EU Data Protection Regulation: Looming closer . . .
April 22, 2013| Blog| Viewpoint
The UK Patent Box – Clawing Some Money Back from the Taxman
April 18, 2013| Advisory| Viewpoint
FLSA Collective Action: Supreme Court Holds Offer of Judgment Moots Claim
April 18, 2013| Blog| Viewpoint
OIG Issues Updated Self-Disclosure Protocol
April 17, 2013| Blog| Viewpoint
2014 Final Call Letter: CMS Raises Medicare Advantage Rates but Foreshadows Other Significant Program Changes
April 16, 2013| Advisory| Viewpoint
CMS Officially Launches National Physician Payment Transparency Program Website
April 15, 2013| Blog| Viewpoint
President’s 2014 Budget Proposal for the Department of Health and Human Services (HHS)
April 12, 2013| Advisory| Viewpoint
News & Press Releases
Mintz Welcomes Corporate Member Ruth Jin in New York
July 21, 2025
Ruth Jin has joined Mintz as a Member in the firm’s Corporate Practice with a focus on investment fund formation, liquidity strategies, governance, investment transactions, and securities offerings.
San Francisco Business Times featured Mintz’s new office lease in San Francisco at 525 Market St. The firm will be increasing its footprint in downtown by 50% to 29,000 square feet on a whole single floor with the new space.
Mintz advised the underwriters in connection with a $230 million public offering by Cogent Biosciences, Inc. of 25,555,556 shares of common stock, which includes 3,333,333 shares issued pursuant to the exercise in full by the underwriters of their option to purchase additional shares of common stock, offered at a public offering price of $9.00 per share. The aggregate gross proceeds to Cogent from this offering were approximately $230 million, including proceeds from the exercise in full by the underwriters of the option to purchase additional shares, before deducting underwriting discounts and commissions and other offering expenses.
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|